Healthcare, Pharma & Life Sciences

Global – October 21, 2026 -- The International Society for Cell & Gene Therapy (ISCT) has made cold-chain readiness a specific focus for 2026, and SpotSee is outlining how shippers can match temperature-monitoring technology to the evidence their quality teams need.

ISCT's Cold Chain Management and Logistics Working Group is addressing cryopreservation, storage, shipping, handling and thawing. Therapies can pass through manufacturing sites, storage locations, specialized logistics providers and clinical sites. For autologous therapies, patient-derived material is collected, shipped for manufacturing and returned to the same patient, so each hand-off may require proof that temperature requirements held.

Waltham – October 19, 2026 -- Lumicell, Inc. has promoted Chief Commercial Officer Marnie Curbow to Chief Executive Officer, effective immediately, less than a year after she joined the fluorescence-guided cancer surgery company.

Curbow rose from VP of Sales to CEO within roughly 12 months

Curbow joined Lumicell in October 2025 as Vice President of Sales. She was then promoted to Chief Commercial Officer, with responsibility for sales, marketing, reimbursement and clinical applications. Lumicell credits her with building its commercial organization and strengthening its go-to-market strategy.

Before Lumicell, she served as GM & VP Sales Diagnostics for the Americas at Rhinomed, where she launched a novel diagnostic and secured a SPARK accelerator award from BARDA. She brings nearly two decades of experience across breast oncology, surgery, diagnostics and therapeutics.

San Mateo – October 19, 2026 -- Helix will present three-year outcomes from CDC Tier 1 genomic screening of 527,000 participants at the opening plenary of the American Society of Human Genetics (ASHG) 2026 Annual Meeting, held October 20-24 in Montreal. The company says its GenoSphereTM resource now holds more than 620,000 paired EHR, claims and genomics records.

Helix Research Network supplies the plenary data from 17 health systems

The plenary study draws on the Helix Research Network (HRN), which Helix describes as the world's largest precision health network. All 17 member health systems offer CDC Tier 1 primary screening to every patient who enrolls in research. The study examines how surfacing previously undiagnosed genetic risk can improve screening and preventive care across diverse health systems.

Cassie Hajek, MD, Medical Director, will deliver the talk on Tuesday, October 20, from 5:57 to 6:15 p.m. ET in Room 517.

Washington – October 19, 2026 -- Tigerlily Foundation will hold two events at the Grand Hyatt Washington on Saturday, October 24, 2026, marking 20 years of operations: the 4th Annual BEACON Symposium and the 20th Anniversary EmPOWER Ball.

BEACON Symposium runs 9:30 a.m. to 2:00 p.m. ET on clinical trials and drug pricing

The daytime program, titled "Transformation with Patients Leading in Healthcare," will run under the theme "From Access to Action: Scaling Patient-Led Solutions for an Equitable Future." It will gather patient advocates, healthcare leaders, providers and scientific experts.

Two topics anchor the agenda: building more equitable, community-centered clinical trials, and how drug pricing policies affect patients and access. Organizers say collaborative sessions are designed to move participants from identifying problems to contributing potential solutions.

Parsippany-Troy Hills, N.J. – October 19, 2026 -- Navigator Group Purchasing has named Experience Fresh its preferred marketing services provider, giving senior living members preferred pricing and priority access to a marketing program that claims a 3X return on ad spend.

The agreement extends Navigator's cost-reduction model into occupancy growth. Navigator has spent more than 30 years helping senior living operators cut costs, improve operations and optimize purchasing. Experience Fresh adds occupancy growth, census development, brand strategy and demand generation.

Torrington – October 19, 2026 -- Therap Services will unveil new AI Analyses and expanded Fatal Five health tracking at a virtual showcase on October 20, 2026, with the AI tools offered at no additional cost to Therap users.

Therap AI Analyses consolidate data across platform modules

The tools pull and evaluate documentation from multiple modules to produce person-centered insights and high-level summaries. Therap says the output helps human services providers streamline daily reviews and strengthen clinical oversight. The product targets a common problem: clinical and administrative teams struggle to identify underlying health trends and programmatic progress across agency-wide documentation.

San Diego – October 19, 2026 -- eGlint, Inc. won the $250,000 Grand Prize at the 2026 BioTools Innovator Capstone Competition on October 14, giving the rapid-proteomics developer fresh capital as it moves its first product, ProteoMix, toward commercialization.

eGlint beat three other finalists, Caravel, Pando Bioscience and QuantumCyte, in a live competition. The four were drawn from the 30-company 2026 accelerator cohort, which was selected from more than 550 applicants worldwide. Attendees, including life science executives, investors and strategic partners, decided the winner by live audience vote.

New York – October 19, 2026 -- Amsterdam Nursing Home has been ranked #36 among New York nursing homes with 150 beds or more in Newsweek's America's Best Nursing Homes 2027, its fourth consecutive year on the list.

Newsweek and Statista screen 14,693 facilities to select 1,325

The 2027 ranking recognizes 1,325 of the nation's top nursing homes out of 14,693 analyzed, meaning roughly 9% of the facilities evaluated made the cut. Newsweek compiles the list each year with the global data research firm Statista.

The evaluation draws on performance data, peer recommendations, accreditations and satisfaction metrics. It also uses data from the Centers for Medicare & Medicaid Services (CMS).

Boca Raton – October 19, 2026 -- Empyrean Medical Systems has submitted a 510(k) premarket notification to the U.S. Food and Drug Administration for Vektra, its robotically assisted brachytherapy and intraoperative radiation therapy (IORT) system, completing a planned milestone in the company's move into clinical radiation oncology.

Vektra targets a segment treating about 15% of radiation oncology patients

Empyrean describes Vektra as the world's first robotically assisted, rapid beam-sculpting X-ray photon platform for brachytherapy and IORT. The system is designed to deliver conformal doses to malignant tumors while limiting dose to healthy tissue and organs at risk. Brachytherapy and IORT together treat approximately 15% of patients receiving radiation oncology care, according to the International Atomic Energy Agency (IAEA) figure cited by the company.

Stanford – October 19, 2026 -- Stanford University PhD student Samuel King used a generative AI model in 2025 to propose genetic blueprints for microscopic viruses, a preliminary answer to whether AI can design new life forms. The work is not yet an example of AI-generated life, though that could be the next step.

MIT Technology Review puts King in a subscriber-only roundtable

MIT Technology Review senior AI reporter James O'Donnell interviewed King, a bioengineering PhD candidate at Stanford University and the Arc Institute. The session was recorded on Friday, October 16, 2026, and is available only to subscribers.

King's virus work earned an Innovators Under 35 selection

MIT Technology Review named King one of its Innovators Under 35. The conversation covers his research, the recognition and what the publication describes as new ways of seeing biology.